Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa-Reference-Cited by-同舟云学术

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa

Published:2013-11-13 Issue:17 Volume:27 Page:2775-2786
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Amornkul Pauli N.,Karita Etienne,Kamali Anatoli,Rida Wasima N.,Sanders Eduard J.,Lakhi Shabir,Price Matt A.,Kilembe William,Cormier Emmanuel,Anzala Omu,Latka Mary H.,Bekker Linda-Gail,Allen Susan A.,Gilmour Jill,Fast Patricia E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference34 articles.

1. Prevention of sexual transmission of HIV: real results, science progressing, societies remaining behind.;Laga;AIDS,2012

2. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.;Hemelaar;AIDS,2006

3. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991.;Hessol;Am J Epidemiol,1994

4. Associations of age, immunosuppression, and AIDS among homosexual men in the Tricontinental Seroconverter Study.;Veugelers;J Acquir Immune Defic Syndr Hum Retrovirol,1997

5. Comparison of progression and nonprogression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.;Prins;AIDS,1997

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective study of the prevalence of acquired drug resistance after failed antiretroviral therapy in Libya;E MEDITERR HEALTH J;2024

2. A validated in-house assay for HIV drug resistance mutation surveillance from dried blood spot specimens;Journal of Virological Methods;2024-06

3. The effect of antiretroviral therapy in newly diagnosed people living with HIV and AIDS, and their correlation with common inflammatory markers and lipid profile;HIV & AIDS Review;2024-05-13

4. Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial;AIDS;2024-03-13

5. HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study;Open Forum Infectious Diseases;2024-03-13